Literature DB >> 8898855

Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation.

R Cargnello1, M R Celio, B Schwaller, V Gotzos.   

Abstract

Calretinin is a Ca(2+)-binding protein of the EF-hand family which is expressed in colon adenocarcinomas and colon-derived tumor cell lines (e.g. WiDr), but is absent from normal human enterocytes. Its function has not as yet been elucidated, but some lines of evidence lead us to postulate its involvement in cell proliferation in these cells. In order to test whether calretinin is correlated with an undifferentiated, proliferating, or with a differentiated, state of cells, its expression was studied in the human colon adenocarcinoma clonal cell line HT29-18, which can be caused to differentiate into enterocyte-like cells by replacing glucose with galactose in the culture medium (glucose starvation differentiation). Treatment of HT29-18 cells with galactose led to a drop in the calretinin mRNA level and in protein expression as evidenced by immunocytochemical staining and Western blot analysis of cytosolic cell extracts. These results suggest that calretinin is present in HT29-18 cancer cells, mostly in those which are in the undifferentiated state. The possibility that calretinin is involved in maintaining the cells in an undifferentiated (cancerous) state is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898855     DOI: 10.1016/0167-4889(96)00090-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Authors:  Brody Winn; Rosemarie Tavares; Jacqueline Fanion; Lelia Noble; John Gao; Edmond Sabo; Murray B Resnick
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

2.  Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.

Authors:  Abd AlRahman Mohammad Foda; Amira Kamal El-Hawary; Hazem Hamed
Journal:  Pathol Oncol Res       Date:  2016-04-09       Impact factor: 3.201

3.  Parallel mRNA, proteomics and miRNA expression analysis in cell line models of the intestine.

Authors:  Finbarr O'Sullivan; Joanne Keenan; Sinead Aherne; Fiona O'Neill; Colin Clarke; Michael Henry; Paula Meleady; Laura Breen; Niall Barron; Martin Clynes; Karina Horgan; Padraig Doolan; Richard Murphy
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.